The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Next 5 Years (per annum) N/A N/A N/A N/A Past 5 Years (per annum)-32.69% N/A N/A N/A ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Up last 7 days N/A N/A N/A N/A Up last 30 days N/A N/A N/A N/A Down last 7 days N/A N/A N/A N/A Down last 30 days N/A N/A N/A N/A ...
Up Last 7 Days N/A N/A N/A N/A Up Last 30 Days N/A N/A N/A N/A Down Last 7 Days N/A N/A N/A N/A Down Last 30 Days N/A N/A N/A N/A Next 5 Years (per annum) N/A N/A N/A ...
Up last 7 days N/A N/A N/A N/A Up last 30 days N/A N/A N/A N/A Down last 7 days N/A N/A N/A N/A Down last 30 days N/A N/A N/A N/A Next 5 years (per annum) N/A N/A N/A ...
Caliper Life Sciences, Inc. has launched the Staccato Protein Workstation to specifically address bottlenecks in the characterization of biological therapeutics and biogenerics. With a goal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback